v3.25.3
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of shares for services, shares             605,896 114,545    
Issuance of stock for services         $ 5,894 $ 4,200 $ 71,734 $ 10,094    
Issuance of common stock for purchase of assets, shares             672,520 0    
Issuance of common stock for purchase of assets             $ 67,253 $ 0    
Convrsion of debt $ 50,000           50,000      
Proceeds from warrant exercises             6,250    
Unvested warrants issued       100,000            
Fair value of warrants             24,477 9,947    
Share based compensation $ 258,562     $ 134,987     $ 698,049 444,001    
Weighted average exercise price of outstanding $ 0.13           $ 0.13      
Weighted average exercise price of outstanding vested options $ 0.13           $ 0.13      
Weighted average remaining life outstanding             6 years 7 months 6 days      
Weighted average remaining life vested             5 years 10 months 24 days      
Options outstanding intrinsic value $ 2,707,390           $ 2,707,390      
Total intrinsic value 5,448,826           $ 5,448,826      
Stock option vesting, description             At September 30, 2025, remaining compensation to be recognized as future vesting of stock options is approximately $5.6 million of which approximately $0.7 million will vest with a weighted average remaining vesting period of approximately 1 year, and approximately $4.9 million will vest upon the probability of achieving performance milestone criteria      
General and Administrative Expense [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation 55,820     7,541     $ 293,955 53,262    
Research and Development Expense [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Share based compensation $ 202,742     $ 127,446     $ 404,095 $ 390,739    
Common Stock [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of shares for services, shares         62,045 52,500        
Issuance of stock for services         $ 62 $ 52        
Issuance of shares on the conversion of debt ,shares     625,000 2,812,500     625,000      
Issuance of common stock due to cashless exercise, shares 233,721 106,687 44,000       384,408      
Warrants exercised issued   125,000                
Issuance of common stock and warrants for cash through private placements, shares 1,750,000 2,600,000                
Common Stock [Member] | Private Placement [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of common stock and warrants for cash through private placements, shares             4,350,000      
Proceeds from issuance of private placement             $ 435,000      
Common Stock [Member] | Director [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Stock option exercise, shares             650,000      
Warrants exercised issued             125,000      
Warrant [Member]                    
Accumulated Other Comprehensive Income (Loss) [Line Items]                    
Issuance of shares for services, shares             250,000 177,500    
Issuance of stock for services             $ 22,936 $ 11,844    
Issuance of shares on the conversion of debt ,shares             625,000      
Exercise price, per share $ 0.10           $ 0.10      
Debt instrument, term             5 years      
Unvested warrants issued             500,000      
Fair value of warrants             $ 50,231      
Issuance of warrants for interest, shares             250,000 150,000    
Issuance of warrants for interest, value             $ 24,477 $ 9,947    
Weighted average exercise price $ 0.20           $ 0.20   $ 0.21 $ 0.22
Weighted average remaining term             3 years